Conde-Knape makes the future of pharmaceuticals possible at Novo Nordisk

Karin Conde-Knape became the senior vice president of global drug discovery at Novo Nordisk a little over a year ago. Here, she's in charge of preliminary research withinin several therapy areas that are of interest to the pharmaceutical giant.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk has begun phase III trial with antibody
For subscribers